MRX-15

N/A

Report date: 2021/12/10 17:23:14
NME

Base Information

Drug NameMRX-15
Drug Alias NameMRX-15
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai MicuRx Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai MicuRx Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A